Viewing Study NCT06430541



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06430541
Status: RECRUITING
Last Update Posted: 2024-06-27
First Post: 2024-05-21

Brief Title: Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Sponsor: University of Colorado Denver
Organization: University of Colorado Denver

Study Overview

Official Title: Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed with Early-stage Breast Cancer and Ovarian Cancer in Remission
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to test whether psilocybin along with therapy in women with early breast cancer and ovarian cancer in remission can improve their fear of recurrence The main questions it aims to answer isare

Does psilocybin assisted therapy improve fear of cancer recurrence Does psilocybin assisted therapy improve anxiety depression and quality of life

Participants will complete a series of survey measures participate in preparatory therapy After prep therapy is complete they will receive a moderately high dose of psilocybin in a monitored and supportive environment After the dosing day they will complete 4 sessions of integrative therapy and complete survey measures
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None